Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Darifenacin for Ureteric Stent Symptoms
NCT07206706Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil, darifenacin in lower urinary tract symptoms (LUTS), pain, sponsored by Ain Shams University. Started May 2022; status: completed.
02
Drugs
tadalafildarifenacin
03
Conditions
lower urinary tract symptoms (LUTS)pain
Beyond the preview
Go deeper on NCT07206706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206706.